<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-10-03" modified="2020-08-12" version="156">
<accession>Q8IZL8</accession>
<accession>O15450</accession>
<accession>Q5EGN3</accession>
<accession>Q6NTE6</accession>
<accession>Q96FT1</accession>
<accession>Q9BU60</accession>
<name>PELP1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Proline-, glutamic acid- and leucine-rich protein 1</fullName>
</recommendedName>
<alternativeName>
<fullName>Modulator of non-genomic activity of estrogen receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>Transcription factor HMX3</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PELP1</name>
<name type="synonym">HMX3</name>
<name type="synonym">MNAR</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="14783" last="14788">
<title>Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade.</title>
<authorList>
<person name="Wong C.-W."/>
<person name="McNally C."/>
<person name="Nickbarg E."/>
<person name="Komm B.S."/>
<person name="Cheskis B.J."/>
</authorList>
<dbReference type="PubMed" id="12415108"/>
<dbReference type="DOI" id="10.1073/pnas.192569699"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ESR1; ESR2; AR; NR3C1 AND SRC</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Lung</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="38272" last="38279">
<title>Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.</title>
<authorList>
<person name="Vadlamudi R.K."/>
<person name="Wang R.-A."/>
<person name="Mazumdar A."/>
<person name="Kim Y.-S."/>
<person name="Shin J."/>
<person name="Sahin A."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="11481323"/>
<dbReference type="DOI" id="10.1074/jbc.m103783200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-356</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ESR1; CREBBP AND EP300</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-01" db="EMBL/GenBank/DDBJ databases">
<title>Human transcription factor HMX3.</title>
<authorList>
<person name="Lei W."/>
<person name="Harrod K.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 70-1130</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="22119" last="22127">
<title>Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.</title>
<authorList>
<person name="Balasenthil S."/>
<person name="Vadlamudi R.K."/>
</authorList>
<dbReference type="PubMed" id="12682072"/>
<dbReference type="DOI" id="10.1074/jbc.m212822200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RB1</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Mol. Endocrinol." volume="18" first="1096" last="1108">
<title>Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc.</title>
<authorList>
<person name="Barletta F."/>
<person name="Wong C.-W."/>
<person name="McNally C."/>
<person name="Komm B.S."/>
<person name="Katzenellenbogen B."/>
<person name="Cheskis B.J."/>
</authorList>
<dbReference type="PubMed" id="14963108"/>
<dbReference type="DOI" id="10.1210/me.2003-0335"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ESR1 AND SRC</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Cancer Res." volume="64" first="6416" last="6423">
<title>Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells.</title>
<authorList>
<person name="Nair S.S."/>
<person name="Mishra S.K."/>
<person name="Yang Z."/>
<person name="Balasenthil S."/>
<person name="Kumar R."/>
<person name="Vadlamudi R.K."/>
</authorList>
<dbReference type="PubMed" id="15374949"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-04-1786"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HISTONE H1 AND H3</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="50930" last="50941">
<title>The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains.</title>
<authorList>
<person name="Choi Y.B."/>
<person name="Ko J.K."/>
<person name="Shin J."/>
</authorList>
<dbReference type="PubMed" id="15456770"/>
<dbReference type="DOI" id="10.1074/jbc.m406831200"/>
</citation>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>INTERACTION WITH HDAC2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="J. Clin. Endocrinol. Metab." volume="89" first="6130" last="6138">
<title>Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.</title>
<authorList>
<person name="Vadlamudi R.K."/>
<person name="Balasenthil S."/>
<person name="Broaddus R.R."/>
<person name="Gustafsson J.-A."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="15579769"/>
<dbReference type="DOI" id="10.1210/jc.2004-0909"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="7724" last="7732">
<title>Functional implications of altered subcellular localization of PELP1 in breast cancer cells.</title>
<authorList>
<person name="Vadlamudi R.K."/>
<person name="Manavathi B."/>
<person name="Balasenthil S."/>
<person name="Nair S.S."/>
<person name="Yang Z."/>
<person name="Sahin A.A."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="16140940"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-05-0614"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PI3K AND EGFR</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="5571" last="5577">
<title>Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.</title>
<authorList>
<person name="Manavathi B."/>
<person name="Nair S.S."/>
<person name="Wang R.-A."/>
<person name="Kumar R."/>
<person name="Vadlamudi R.K."/>
</authorList>
<dbReference type="PubMed" id="15994929"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-04-4664"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH STAT3</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Cell" volume="121" first="873" last="885">
<title>Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.</title>
<authorList>
<person name="Dou Y."/>
<person name="Milne T.A."/>
<person name="Tackett A.J."/>
<person name="Smith E.R."/>
<person name="Fukuda A."/>
<person name="Wysocka J."/>
<person name="Allis C.D."/>
<person name="Chait B.T."/>
<person name="Hess J.L."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="15960975"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.04.031"/>
</citation>
<scope>IDENTIFICATION IN THE MLL1/MLL COMPLEX</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-481</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="15394" last="15404">
<title>9-cis-retinoic acid up-regulates expression of transcriptional coregulator PELP1, a novel coactivator of the retinoid X receptor alpha pathway.</title>
<authorList>
<person name="Singh R.R."/>
<person name="Gururaj A.E."/>
<person name="Vadlamudi R.K."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="16574651"/>
<dbReference type="DOI" id="10.1074/jbc.m601593200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RXRA</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="4395" last="4403">
<title>Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) interacts with PELP1 and activates MAPK.</title>
<authorList>
<person name="Rayala S.K."/>
<person name="den Hollander P."/>
<person name="Balasenthil S."/>
<person name="Molli P.R."/>
<person name="Bean A.J."/>
<person name="Vadlamudi R.K."/>
<person name="Wang R.-A."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="16352611"/>
<dbReference type="DOI" id="10.1074/jbc.m510368200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HRS</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="5308" last="5313">
<title>NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression.</title>
<authorList>
<person name="Rosendorff A."/>
<person name="Sakakibara S."/>
<person name="Lu S."/>
<person name="Kieff E."/>
<person name="Xuan Y."/>
<person name="DiBacco A."/>
<person name="Shi Y."/>
<person name="Shi Y."/>
<person name="Gill G."/>
</authorList>
<dbReference type="PubMed" id="16567619"/>
<dbReference type="DOI" id="10.1073/pnas.0601066103"/>
</citation>
<scope>INTERACTION WITH SUMO2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Mol. Endocrinol." volume="21" first="1847" last="1860">
<title>Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1).</title>
<authorList>
<person name="Gururaj A.E."/>
<person name="Peng S."/>
<person name="Vadlamudi R.K."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="17505058"/>
<dbReference type="DOI" id="10.1210/me.2006-0514"/>
</citation>
<scope>INTERACTION WITH BCAS3</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1033</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-477; SER-481; THR-745 AND SER-1043</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-477; SER-481 AND SER-1033</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="EMBO J." volume="30" first="1067" last="1078">
<title>The SUMO system controls nucleolar partitioning of a novel mammalian ribosome biogenesis complex.</title>
<authorList>
<person name="Finkbeiner E."/>
<person name="Haindl M."/>
<person name="Muller S."/>
</authorList>
<dbReference type="PubMed" id="21326211"/>
<dbReference type="DOI" id="10.1038/emboj.2011.33"/>
</citation>
<scope>IDENTIFICATION IN THE PELP1 COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUMOYLATION AT LYS-826</scope>
<scope>MUTAGENESIS OF LYS-826</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-477; SER-481; THR-488; THR-745; SER-1033 AND SER-1043</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="1263" last="1273">
<title>Five friends of methylated chromatin target of protein-arginine-methyltransferase[prmt]-1 (chtop), a complex linking arginine methylation to desumoylation.</title>
<authorList>
<person name="Fanis P."/>
<person name="Gillemans N."/>
<person name="Aghajanirefah A."/>
<person name="Pourfarzad F."/>
<person name="Demmers J."/>
<person name="Esteghamat F."/>
<person name="Vadlamudi R.K."/>
<person name="Grosveld F."/>
<person name="Philipsen S."/>
<person name="van Dijk T.B."/>
</authorList>
<dbReference type="PubMed" id="22872859"/>
<dbReference type="DOI" id="10.1074/mcp.m112.017194"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE 5FMC COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-477; SER-481 AND SER-1033</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-481</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2016" name="Mol. Cell" volume="64" first="607" last="615">
<title>The AAA ATPase MDN1 acts as a SUMO-targeted regulator in mammalian pre-ribosome remodeling.</title>
<authorList>
<person name="Raman N."/>
<person name="Weir E."/>
<person name="Mueller S."/>
</authorList>
<dbReference type="PubMed" id="27814492"/>
<dbReference type="DOI" id="10.1016/j.molcel.2016.09.039"/>
</citation>
<scope>SUMOYLATION</scope>
<scope>INTERACTION WITH MDN1</scope>
</reference>
<comment type="function">
<text evidence="12 13 14 15 16 17 18 20 21 22 24 26 27">Coactivator of estrogen receptor-mediated transcription and a corepressor of other nuclear hormone receptors and sequence-specific transcription factors. Plays a role in estrogen receptor (ER) genomic activity when present in the nuclear compartment by activating the ER target genes in a hormonal stimulation dependent manner. Can facilitate ER non-genomic signaling via SRC and PI3K interaction in the cytosol. Plays a role in E2-mediated cell cycle progression by interacting with RB1. May have important functional implications in ER/growth factor cross-talk. Interacts with several growth factor signaling components including EGFR and HRS. Involved in nuclear receptor signaling via its interaction with AR and NR3C1. May promote tumorigenesis via its interaction with and modulation of several oncogenes including SRC, PI3K, STAT3 and EGFR. Plays a role in cancer cell metastasis via its ability to modulate E2-mediated cytoskeleton changes and cell migration via its interaction with SRC and PI3K. Functions as the key stabilizing component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes. Component of the PELP1 complex involved in the nucleolar steps of 28S rRNA maturation and the subsequent nucleoplasmic transit of the pre-60S ribosomal subunit. Regulates pre-60S association of the critical remodeling factor MDN1 (PubMed:21326211).</text>
</comment>
<comment type="subunit">
<text evidence="12 13 14 15 16 17 19 20 21 22 23 24 25 26 27 28">Interacts with HRS, RXRA, SUMO2, HDAC2, RB1 and STAT3. Interacts with PI3K, SRC and EGFR in cytoplasm. Interacts with ESR1 and ESR2 and this interaction is enhanced by 17-beta-estradiol. Interacts with CREBBP, EP300, AR and NR3C1 in a ligand-dependent manner. Forms two complexes in the presence of 17-beta-estradiol; one with SRC and ESR1 and another with LCK and ESR1. Interacts with histone H1 and H3 with a greater affinity for H1. Component of some MLL1/MLL complex, at least composed of the core components KMT2A/MLL1, ASH2L, HCFC1/HCF1, WDR5 and RBBP5, as well as the facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MGA, KAT8/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. Core component of the 5FMC complex, at least composed of PELP1, LAS1L, TEX10, WDR18 and SENP3; the complex interacts with methylated CHTOP and ZNF148. Interacts with NOL9. Interacts with BCAS3. Component of the PELP1 complex, composed of at least PELP1, TEX10 and WDR18. The complex interacts (via PELP1) with MDN1 (via its hexameric AAA ATPase ring) and the pre-60S ribosome particles (PubMed:21326211, PubMed:27814492).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716449">
<id>Q8IZL8</id>
</interactant>
<interactant intactId="EBI-120658">
<id>P84243</id>
<label>H3-3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716449">
<id>Q8IZL8</id>
</interactant>
<interactant intactId="EBI-710124">
<id>O60341</id>
<label>KDM1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716449">
<id>Q8IZL8</id>
</interactant>
<interactant intactId="EBI-1050480">
<id>Q9NU22</id>
<label>MDN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716449">
<id>Q8IZL8</id>
</interactant>
<interactant intactId="EBI-300010">
<id>P19838</id>
<label>NFKB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716449">
<id>Q8IZL8</id>
</interactant>
<interactant intactId="EBI-78579">
<id>P06748</id>
<label>NPM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716449">
<id>Q8IZL8</id>
</interactant>
<interactant intactId="EBI-2880236">
<id>Q9H4L4</id>
<label>SENP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716449">
<id>Q8IZL8</id>
</interactant>
<interactant intactId="EBI-473220">
<id>P61956</id>
<label>SUMO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-716449">
<id>Q8IZL8</id>
</interactant>
<interactant intactId="EBI-727429">
<id>Q9BV38</id>
<label>WDR18</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="26">Nucleus</location>
<location evidence="26">Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="26">Nucleus</location>
<location evidence="26">Nucleoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text evidence="11 21">Mainly found in the nucleoplasm, with low levels detected in the cytoplasm (By similarity). Also found associated with the plasma membrane. Mainly in cytoplasm in a subset of breast tumors. Localization is widely deregulated in endometrial cancers with predominantly cytoplasm localization in high-grade endometrial tumors (PubMed:16140940).</text>
</comment>
<comment type="tissue specificity">
<text evidence="12">Widely expressed.</text>
</comment>
<comment type="domain">
<text>The Glu-rich region mediates histones interaction.</text>
</comment>
<comment type="domain">
<text>The Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs are required for the association with nuclear receptor ESR1.</text>
</comment>
<comment type="PTM">
<text evidence="26 28">Transiently sumoylated, preferentially conjugated to SUMO2 or SUMO3. Sumoylation causes nucleolar exclusion of PELP1 and promotes the recruitment of MDN1 to pre-60S particles. Desumoylation by SUMO isopeptidase SENP3 is needed to release both PELP1 and MDN1 from pre-ribosomes.</text>
</comment>
<comment type="similarity">
<text evidence="29">Belongs to the RIX1/PELP1 family.</text>
</comment>
<comment type="sequence caution" evidence="29">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAC17708" version="2"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="29">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAC17708" version="2"/>
</conflict>
<text>Intron retention.</text>
</comment>
<dbReference type="EMBL" id="AF547989">
<property type="protein sequence ID" value="AAN41255.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC002875">
<property type="protein sequence ID" value="AAH02875.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC010457">
<property type="protein sequence ID" value="AAH10457.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC069058">
<property type="protein sequence ID" value="AAH69058.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U88153">
<property type="protein sequence ID" value="AAC17708.2"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY882602">
<property type="protein sequence ID" value="AAW80659.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58503.2"/>
<dbReference type="RefSeq" id="NP_001265170.1">
<property type="nucleotide sequence ID" value="NM_001278241.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_055204.3">
<property type="nucleotide sequence ID" value="NM_014389.2"/>
</dbReference>
<dbReference type="BioGRID" id="117973">
<property type="interactions" value="83"/>
</dbReference>
<dbReference type="CORUM" id="Q8IZL8"/>
<dbReference type="ELM" id="Q8IZL8"/>
<dbReference type="IntAct" id="Q8IZL8">
<property type="interactions" value="35"/>
</dbReference>
<dbReference type="MINT" id="Q8IZL8"/>
<dbReference type="STRING" id="9606.ENSP00000301396"/>
<dbReference type="iPTMnet" id="Q8IZL8"/>
<dbReference type="MetOSite" id="Q8IZL8"/>
<dbReference type="PhosphoSitePlus" id="Q8IZL8"/>
<dbReference type="SwissPalm" id="Q8IZL8"/>
<dbReference type="BioMuta" id="PELP1"/>
<dbReference type="DMDM" id="115502553"/>
<dbReference type="CPTAC" id="CPTAC-1629"/>
<dbReference type="EPD" id="Q8IZL8"/>
<dbReference type="jPOST" id="Q8IZL8"/>
<dbReference type="MassIVE" id="Q8IZL8"/>
<dbReference type="MaxQB" id="Q8IZL8"/>
<dbReference type="PaxDb" id="Q8IZL8"/>
<dbReference type="PeptideAtlas" id="Q8IZL8"/>
<dbReference type="PRIDE" id="Q8IZL8"/>
<dbReference type="ProteomicsDB" id="71367"/>
<dbReference type="Antibodypedia" id="23315">
<property type="antibodies" value="258 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000572293">
<property type="protein sequence ID" value="ENSP00000460300"/>
<property type="gene ID" value="ENSG00000141456"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000574876">
<property type="protein sequence ID" value="ENSP00000461625"/>
<property type="gene ID" value="ENSG00000141456"/>
</dbReference>
<dbReference type="GeneID" id="27043"/>
<dbReference type="KEGG" id="hsa:27043"/>
<dbReference type="UCSC" id="uc059zun.1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="27043"/>
<dbReference type="DisGeNET" id="27043"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000141456.14"/>
<dbReference type="GeneCards" id="PELP1"/>
<dbReference type="HGNC" id="HGNC:30134">
<property type="gene designation" value="PELP1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000141456">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="609455">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8IZL8"/>
<dbReference type="OpenTargets" id="ENSG00000141456"/>
<dbReference type="PharmGKB" id="PA142671186"/>
<dbReference type="eggNOG" id="ENOG502QQE7">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00730000111225"/>
<dbReference type="InParanoid" id="Q8IZL8"/>
<dbReference type="KO" id="K16913"/>
<dbReference type="OrthoDB" id="427039at2759"/>
<dbReference type="PhylomeDB" id="Q8IZL8"/>
<dbReference type="PathwayCommons" id="Q8IZL8"/>
<dbReference type="Reactome" id="R-HSA-6791226">
<property type="pathway name" value="Major pathway of rRNA processing in the nucleolus and cytosol"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849473">
<property type="pathway name" value="PTK6 Expression"/>
</dbReference>
<dbReference type="SIGNOR" id="Q8IZL8"/>
<dbReference type="BioGRID-ORCS" id="27043">
<property type="hits" value="579 hits in 803 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PELP1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GenomeRNAi" id="27043"/>
<dbReference type="Pharos" id="Q8IZL8">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q8IZL8"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="Q8IZL8">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000141456">
<property type="expression patterns" value="Expressed in amniotic fluid and 247 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q8IZL8">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8IZL8">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071339">
<property type="term" value="C:MLL1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0035327">
<property type="term" value="C:transcriptionally active chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071391">
<property type="term" value="P:cellular response to estrogen stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006364">
<property type="term" value="P:rRNA processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR016024">
<property type="entry name" value="ARM-type_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR012583">
<property type="entry name" value="RIX1_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR012980">
<property type="entry name" value="Uncharacterised_NUC202"/>
</dbReference>
<dbReference type="Pfam" id="PF08166">
<property type="entry name" value="NUC202"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF08167">
<property type="entry name" value="RIX1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48371">
<property type="entry name" value="SSF48371"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="4 7 8">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Proline-, glutamic acid- and leucine-rich protein 1" id="PRO_0000252135">
<location>
<begin position="2"/>
<end position="1130"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 1">
<location>
<begin position="33"/>
<end position="37"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 2">
<location>
<begin position="69"/>
<end position="73"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 3">
<location>
<begin position="111"/>
<end position="115"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 4">
<location>
<begin position="155"/>
<end position="159"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 5">
<location>
<begin position="177"/>
<end position="181"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 6">
<location>
<begin position="264"/>
<end position="268"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 7">
<location>
<begin position="271"/>
<end position="275"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 8">
<location>
<begin position="364"/>
<end position="368"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 9">
<location>
<begin position="459"/>
<end position="463"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 10">
<location>
<begin position="579"/>
<end position="583"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 11">
<location>
<begin position="584"/>
<end position="588"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="633"/>
<end position="872"/>
</location>
</feature>
<feature type="compositionally biased region" description="Glu-rich">
<location>
<begin position="888"/>
<end position="1101"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="977"/>
<end position="1083"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="4 7 8">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="13"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5 6 9">
<location>
<position position="477"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 3 5 6 9 10">
<location>
<position position="481"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="488"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3 6">
<location>
<position position="745"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5 6 9">
<location>
<position position="1033"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 6">
<location>
<position position="1043"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="26">
<location>
<position position="826"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9436." id="VAR_027766">
<original>T</original>
<variation>S</variation>
<location>
<position position="1126"/>
</location>
</feature>
<feature type="mutagenesis site" description="Not sumoylated." evidence="26">
<original>K</original>
<variation>R</variation>
<location>
<position position="826"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC17708." ref="3" evidence="29">
<original>A</original>
<variation>V</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAN41255." ref="1" evidence="29">
<original>E</original>
<variation>G</variation>
<location>
<position position="896"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAN41255." ref="1" evidence="29">
<original>T</original>
<variation>P</variation>
<location>
<position position="1069"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9DBD5"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11481323"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12415108"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12682072"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14963108"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15374949"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15456770"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15579769"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15960975"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15994929"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16140940"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16352611"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16567619"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16574651"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17505058"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21326211"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22872859"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27814492"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305"/>
<sequence length="1130" mass="119700" checksum="7B0DEE7A198DA9A6" modified="2006-10-03" version="2">MAAAVLSGPSAGSAAGVPGGTGGLSAVSSGPRLRLLLLESVSGLLQPRTGSAVAPVHPPNRSAPHLPGLMCLLRLHGSVGGAQNLSALGALVSLSNARLSSIKTRFEGLCLLSLLVGESPTELFQQHCVSWLRSIQQVLQTQDPPATMELAVAVLRDLLRYAAQLPALFRDISMNHLPGLLTSLLGLRPECEQSALEGMKACMTYFPRACGSLKGKLASFFLSRVDALSPQLQQLACECYSRLPSLGAGFSQGLKHTESWEQELHSLLASLHTLLGALYEGAETAPVQNEGPGVEMLLSSEDGDAHVLLQLRQRFSGLARCLGLMLSSEFGAPVSVPVQEILDFICRTLSVSSKNISLHGDGPLRLLLLPSIHLEALDLLSALILACGSRLLRFGILIGRLLPQVLNSWSIGRDSLSPGQERPYSTVRTKVYAILELWVQVCGASAGMLQGGASGEALLTHLLSDISPPADALKLRSPRGSPDGSLQTGKPSAPKKLKLDVGEAMAPPSHRKGDSNANSDVCAAALRGLSRTILMCGPLIKEETHRRLHDLVLPLVMGVQQGEVLGSSPYTSSRCRRELYCLLLALLLAPSPRCPPPLACALQAFSLGQREDSLEVSSFCSEALVTCAALTHPRVPPLQPMGPTCPTPAPVPPPEAPSPFRAPPFHPPGPMPSVGSMPSAGPMPSAGPMPSAGPVPSARPGPPTTANHLGLSVPGLVSVPPRLLPGPENHRAGSNEDPILAPSGTPPPTIPPDETFGGRVPRPAFVHYDKEEASDVEISLESDSDDSVVIVPEGLPPLPPPPPSGATPPPIAPTGPPTASPPVPAKEEPEELPAAPGPLPPPPPPPPPVPGPVTLPPPQLVPEGTPGGGGPPALEEDLTVININSSDEEEEEEEEEEEEEEEEEEEEEDFEEEEEDEEEYFEEEEEEEEEFEEEFEEEEGELEEEEEEEDEEEEEELEEVEDLEFGTAGGEVEEGAPPPPTLPPALPPPESPPKVQPEPEPEPGLLLEVEEPGTEEERGADTAPTLAPEALPSQGEVEREGESPAAGPPPQELVEEEPSAPPTLLEEETEDGSDKVQPPPETPAEEEMETETEAEALQEKEQDDTAAMLADFIDCPPDDEKPPPPTEPDS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

